Human epidermal growth factor receptor 2 (HER2) is a transmembrane tyrosine kinase receptor that plays a pivotal role in the development and progression of cancers, particularly in breast and gastric cancers. While HER2 overexpression is commonly attributed to gene amplification, recent studies indicate that epigenetic modifications, such as DNA methylation, histone modification, and non-coding RNA interference, are also critical in regulating HER2 expression and activity. This article will focus on the relationship between HER2 and epigenetic modification.